Pacer Advisors, Inc. Emergent Bio Solutions Inc. Transaction History

Pacer Advisors, Inc.

$33.6 Billion
Q3 2025

A detailed history of Pacer Advisors, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 536,655 shares of EBS stock, worth $5.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

536,655

Previous 556,730 3.61%

Holding current value

$5.43 Million

Previous $3.55 Million 33.29%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$5.63 - $9.32 $113,022 - $187,099	-20,075 Reduced 3.61%	536,655 $4.73 Million
Q2 2025 Aug 12, 2025	BUY	$4.26 - $6.94 $2.37 Million - $3.86 Million	556,730 New	556,730 $3.55 Million
Q2 2024 Aug 13, 2024	BUY	$1.86 - $6.98 $27 - $104	15 Added 25.0%	75 $0
Q4 2023 Jan 16, 2024	SELL	$1.82 - $3.16 $27 - $47	-15 Reduced 20.0%	60 $0
Q2 2023 Jul 12, 2023	BUY	$7.35 - $13.21 $36 - $66	5 Added 7.14%	75 $0

Q4 2022 Feb 06, 2023	SELL	$11.0 - $21.45 $2.92 Million - $5.69 Million	-265,096 Reduced 99.97%	70 $0
Q3 2022 Oct 18, 2022	BUY	$20.09 - $35.8 $5.32 Million - $9.49 Million	265,054 Added 236655.36%	265,166 $5.57 Million
Q1 2022 Apr 05, 2022	SELL	$36.48 - $52.22 $984 - $1,409	-27 Reduced 19.42%	112 $5,000
Q4 2021 Feb 03, 2022	SELL	$33.11 - $55.01 $167,900 - $278,955	-5,071 Reduced 97.33%	139 $6,000
Q3 2021 Oct 15, 2021	SELL	$50.07 - $66.05 $79,861 - $105,349	-1,595 Reduced 23.44%	5,210 $261,000
Q2 2021 Jul 21, 2021	BUY	$56.61 - $80.46 $40,362 - $57,367	713 Added 11.7%	6,805 $429,000
Q1 2021 Apr 05, 2021	SELL	$86.23 - $125.19 $58,463 - $84,878	-678 Reduced 10.01%	6,092 $566,000
Q4 2020 Jan 20, 2021	SELL	$79.17 - $111.47 $413,663 - $582,430	-5,225 Reduced 43.56%	6,770 $607,000
Q3 2020 Oct 19, 2020	BUY	$81.91 - $134.94 $978,251 - $1.61 Million	11,943 Added 22967.31%	11,995 $1.24 Million
Q2 2020 Jul 29, 2020	BUY	$54.33 - $89.52 $2,825 - $4,655	52 New	52 $4,000
Q1 2019 Apr 10, 2019	SELL	$48.23 - $66.16 $557,876 - $765,272	-11,567 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $470,296 - $619,170	8,454 Added 271.57%	11,567 $686,000
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $162,031 - $207,045	3,113 New	3,113 $205,000
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $56,932 - $65,543	-1,178 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $22,353 - $27,358	503 Added 74.52%	1,178 $62,000
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $25,494 - $32,231	675	675 $31,000

Others Institutions Holding EBS

# of Institutions

191

Shares Held

41.3M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Emergent Bio Solutions Inc. Transaction History